Solven

For research use only. Not for therapeutic Use.

  • CAT Number: I036493
  • CAS Number: 8059-64-1
  • Molecular Formula: C34H47NaO11S
  • Molecular Weight: 686.78
  • Purity: 98%
Inquiry Now

Solven(Cat No.:I036493)is a proprietary compound or formulation that is typically studied for its potential applications in various industries, including pharmaceuticals, chemicals, or biotechnology. The specific details of its structure, mechanism of action, and therapeutic uses may vary depending on the context in which it is being researched. Solven could refer to a solvent used in drug delivery systems or a novel chemical entity being tested for its efficacy in treating specific conditions. Further research, clinical trials, or product development is necessary to fully understand its properties, applications, and safety profile. More context is required for precise information.


Catalog Number I036493
CAS Number 8059-64-1
Synonyms

Solven; Jamylene; DSS-danthron; Danthron – DSS;

Molecular Formula C34H47NaO11S
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
IUPAC Name sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate;1,8-dihydroxyanthracene-9,10-dione
InChI InChI=1S/C20H38O7S.C14H8O4.Na/c1-5-9-11-16(7-3)14-26-19(21)13-18(28(23,24)25)20(22)27-15-17(8-4)12-10-6-2;15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16;/h16-18H,5-15H2,1-4H3,(H,23,24,25);1-6,15-16H;/q;;+1/p-1
InChIKey CMXPERZAMAQXSF-UHFFFAOYSA-M
SMILES CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O.[Na+]
Reference

1: Muhammad Sarfraz R, Bashir S, Mahmood A, Ahsan H, Riaz H, Raza H, Rashid Z, Atif Raza S, Asad Abrar M, Abbas K, Yasmeen T. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW. Acta Pol Pharm. 2017 Mar;74(2):347-356. Review. PubMed PMID: 29624239.
2: Zhang L, Wen Y, He T, Wang M, Xu P. [Determination of residual cyclohexanone in disposable infusion set by gas chromatography]. Zhongguo Yi Liao Qi Xie Za Zhi. 2014 Sep;38(5):381-2, 385. Chinese. PubMed PMID: 25597092.
3: Xu C, Ye Z, Li D, Zhou D, Shui W. [Study on technology in preparation of Fructus Auranti extract]. Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):2971-4. Chinese. PubMed PMID: 22308686.
4: Horisawa E, Kubota K, Tuboi I, Sato K, Yamamoto H, Takeuchi H, Kawashima Y. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res. 2002 Feb;19(2):132-9. PubMed PMID: 11883639.
5: Frize M, Wang L, Ennett CM, Nickerson BG, Solven FG, Stevenson M. New advances and validation of knowledge management tools for critical care using classifier techniques. Proc AMIA Symp. 1998:553-7. PubMed PMID: 9929280; PubMed Central PMCID: PMC2232056.
6: Frize M, Solven FG, Stevenson M, Nickerson B, Buskard T, Taylor K. Computer-assisted decision support systems for patient management in an intensive care unit. Medinfo. 1995;8 Pt 2:1009-12. PubMed PMID: 8591352.
7: Dhingra S, Solven F, Wilson A, McCarthy DS. Hypomagnesemia and respiratory muscle power. Am Rev Respir Dis. 1984 Mar;129(3):497-8. PubMed PMID: 6703506.
8: Newton DW, Murray WJ, Lovell MW. pKa determination of benzhydrylpiperazine antihistamines in aqueous and aqueous methanol solutions. J Pharm Sci. 1982 Dec;71(12):1363-6. PubMed PMID: 6130141.

Request a Quote